SCHEMBL565104

SCHEMBL565104

COc1ccc(C[n+]2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.53
ACHE P22303 2/20 0.48
BCHE P06276 1/20 0.48
HSP90AA1 P07900 1/20 0.47
IDO1 P14902 2/20 0.47
F2 P00734 2/20 0.46
PRSS1 P07477 1/20 0.46
CHKA P35790 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
CA4 P22748 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
AGXT P21549 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4740735 0.98 LTA4H (0.52) LTA4HACHEBCHEHSP90AA1IDO1
SCHEMBL9502792 0.88 LTA4H (0.47) LTA4HACHEBCHEHSP90AA1F2
SCHEMBL18775288 0.85 ALDH1A1 (0.60) LTA4HACHEF2PRSS1CHKA
SCHEMBL7837346 0.84 CHKA (0.49) ACHEBCHEIDO1CHKACA12
SCHEMBL12306074 0.84 CHKA (0.56) LTA4HACHEF2PRSS1CHKA
SCHEMBL9248148 0.83 ALDH1A1 (0.46) LTA4HCA4CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL20719782 0.83 KCNH2 (0.45) LTA4HACHEHSP90AA1CA12CA1
SCHEMBL10325407 0.82 ACHE (0.64) ACHEBCHEF2PRSS1CHKA
Bromide SCHEMBL7860384 0.82 CHKA (0.58) LTA4HF2PRSS1CHKACA4
Bromide SCHEMBL2831425 0.80 ACHE (0.68) ACHEBCHECHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0385504-B1 Heat-latent curing catalyst and resin compositions containing the same NIPPON PAINT CO LTD (JP) 1995-10-04 EP claimed
CN-115160213-B Rheum emodic acid pyridine quaternary ammonium salt compound and synthetic method and application thereof 丽江师范高等专科学校 2024-02-13 CN disclosed
US-9957348-B2 Pyridiniuivi-based compound, epoxy resin composition comprising same, and apparatus manufactured using same SAMSUNG SDI CO., LTD. (KR) 2018-05-01 US disclosed
US-20160333136-A1 PYRIDINIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION COMPRISING SAME, AND APPARATUS MANUFACTURED USING SAME SAMSUNG SDI CO., LTD. (KR) 2016-11-17 US disclosed
US-20160333136-A1 PYRIDINIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION COMPRISING SAME, AND APPARATUS MANUFACTURED USING SAME SAMSUNG SDI CO., LTD. (KR) 2016-11-17 US disclosed
US-20160228356-A1 THE CONTINUOUS LONG-TERM CONTROLLED RELEASE OF TELOMERASE INHIBITORS LASTER, Brenda (IL) 2016-08-11 US disclosed
WO-2015108245-A1 PYRIDINIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION COMPRISING SAME, AND APPARATUS MANUFACTURED USING SAME 제일모직 주식회사 2015-07-23 WO disclosed
US-8729166-B2 Polymer composition for microelectronic assembly PROMERUS, LLC (US) 2014-05-20 US disclosed
US-20140024750-A1 Polymer Composition for Microelectronic Assembly PROMERUS, LLC (US) 2014-01-23 US disclosed
US-8575248-B2 Polymer composition for microelectronic assembly PROMERUS, LLC (US) 2013-11-05 US disclosed
EP-2601239-A1 POLYMER COMPOSITION FOR MICROELECTRONIC ASSEMBLY Promerus, LLC (US) 2013-06-12 EP disclosed
US-20120034387-A1 Polymer Composition for Microelectronic Assembly PROMERUS LLC (US) 2012-02-09 US disclosed
WO-2012019092-A1 POLYMER COMPOSITION FOR MICROELECTRONIC ASSEMBLY PROMERUS LLC (US) 2012-02-09 WO disclosed
EP-0495071-A1 TONERS AND DEVELOPERS CONTAINING N-SUBSTITUTED PYRIDINIUM SALTS AS CHARGE CONTROL AGENTS EASTMAN KODAK COMPANY (US) 1992-07-22 EP disclosed
WO-1992002860-A1 TONERS AND DEVELOPERS CONTAINING N-SUBSTITUTED PYRIDINIUM SALTS AS CHARGE CONTROL AGENTS EASTMAN KODAK COMPANY (US) 1992-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160333136-A1 PYRIDINIUM-BASED COMPOUND, EPOXY RESIN COMPOSITION COMPRISING SAME, AND APPARATUS MANUFACTURED USING SAME EPHX1, VKORC1, VKORC1L1 LTA4H 108/4885ACHE 1189/4885BCHE 1125/4885
US-20160228356-A1 THE CONTINUOUS LONG-TERM CONTROLLED RELEASE OF TELOMERASE INHIBITORS TERT, POT1, TERF2 LTA4H 2498/4885ACHE 3436/4885BCHE 2886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.